Steve Valiquette
Stock Analyst at Barclays
(1.93)
# 2,887
Out of 4,826 analysts
175
Total ratings
46.49%
Success rate
-3.51%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7 → $7.5 | $6.63 | +13.12% | 4 | Apr 16, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $7.15 | +67.83% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.00 | -27.27% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $706.39 | -12.80% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.69 | +91.90% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.81 | +31.41% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $5.15 | +94.17% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $15.06 | +59.36% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $67.10 | +28.17% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $59.78 | +42.19% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $300 | $349.43 | -14.15% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $96.19 | -8.51% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $34.58 | -1.68% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $148.77 | -29.42% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $66.62 | -17.44% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $17.28 | -24.77% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $178.19 | -20.31% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $23.83 | -79.02% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $116.04 | -50.88% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $150.93 | -45.67% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.58 | +2.39% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $36.18 | -14.32% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $319.63 | +17.32% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $28.90 | -34.26% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $256.69 | +122.06% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $151.73 | -57.82% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $333.46 | -7.04% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $404.81 | +39.57% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $7.75 | +867.74% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $2.97 | +539.73% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.86 | +250.26% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $20.52 | +65.69% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $4.73 | +323.28% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $119.13 | +118.25% | 1 | Feb 19, 2021 | |
Brookdale Senior Living
Apr 16, 2025
Maintains: Equal-Weight
Price Target: $7 → $7.5
Current: $6.63
Upside: +13.12%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $7.15
Upside: +67.83%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.00
Upside: -27.27%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $706.39
Upside: -12.80%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.69
Upside: +91.90%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.81
Upside: +31.41%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $5.15
Upside: +94.17%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $15.06
Upside: +59.36%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $67.10
Upside: +28.17%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $59.78
Upside: +42.19%
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $349.43
Upside: -14.15%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $96.19
Upside: -8.51%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $34.58
Upside: -1.68%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $148.77
Upside: -29.42%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $66.62
Upside: -17.44%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $17.28
Upside: -24.77%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $178.19
Upside: -20.31%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $23.83
Upside: -79.02%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $116.04
Upside: -50.88%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $150.93
Upside: -45.67%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.58
Upside: +2.39%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $36.18
Upside: -14.32%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $319.63
Upside: +17.32%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $28.90
Upside: -34.26%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $256.69
Upside: +122.06%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $151.73
Upside: -57.82%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $333.46
Upside: -7.04%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $404.81
Upside: +39.57%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $7.75
Upside: +867.74%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $2.97
Upside: +539.73%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.86
Upside: +250.26%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $20.52
Upside: +65.69%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $4.73
Upside: +323.28%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $119.13
Upside: +118.25%